Benchmarking Phase 4 trial costs

Benchmarking Phase 4 trial costs

Benchmarking Phase 4 clinical trial costs is difficult because the data is almost always “positively skewed.” This means a few extremely expensive trials pull the average up.

We have been able to collect clinical trial cost data from a number of sources, such as US funding databases.

The median cost of trials in our dataset was $1,766,000 and the mean cost was $2,391,000. The standard deviation was $2,787,000. The fact that the standard deviation is greater than the mean, shows just how tricky it is to model trial costs.

Phase 4 Clinical trial funding

Above: histogram of Phase 4 clinical trial costs.

In Phase 4 (Post-Market Surveillance), the scope of a trial can range from a small observational study to a massive, multi-year safety registry involving tens of thousands of patients. A single “mega-trial” for a blockbuster drug (e.g., a cardiovascular safety study) can cost $50M+, which heavily inflates the mean.

Because the mean is so sensitive to these outliers, it often overstates the “expected” cost for a standard trial. The median is a better representation of a “typical” study, but even that misses the massive financial risk of the high-end trials.

A better way to visualise the distribution of the trial costs is to use a log 10 scale on the x axis.

Phase 4 Clinical trial funding

Above: histogram of Phase 4 clinical trial costs using a log 10 scale. You can use the button to toggle through the other phases.

Benchmarking and reference class forecasting

At Fast Data Science, we are working on the next level of clinical trial cost benchmarking: reference class forecasting. For the trial that you want to benchmark for, we can use transformers and vector embeddings to identify similar trials from our database, and apply a correction for inflation.

The tool will display the estimated cost, a lower and upper bound, and the past trials that the cost estimate was based on.

Find out about trial cost benchmarking

Talk to us about your trial cost benchmarking

Get in touch if you would like to subscribe to the tool’s cost benchmarking module and drag and drop your trial protocols and generate benchmark estimates.

Activity based costing for your Phase 4 trial

As an alternative to cost benchmarking, you can model a trial cost, by identifying all activities associated with the trial (such as the assessments in the schedule of events), and sum these items to create a budget. This is complex and time consuming, but creates an itemised budget. The Clinical Trial Risk Tool allows you to build a site budget directly from the protocol PDF.

Above: the Clinical Trial Risk Tool lets you upload a protocol and will automatically check the protocol design against its checklist, as well as generating a site budget for you.

Upload your clinical trial protocol and create a budget with AI

Protocol to budget

Upload your clinical trial protocol in PDF form to the Clinical Trial Risk Tool and create an itemised per-patient and fixed costs budget using our charge masters, or upload your own charge master.

See also

References

  1. Theresia, Yiallourou, et al. “Cost Drivers and Predictive Modeling of Clinical Trial Costs: Analysis of 101 Global Health Trials.” VeriXiv 2.152 (2025): 152.
  2. DiMasi JA, Hansen RW, Grabowski HG: The price of innovation: New estimates of drug development costs. J. Health Econ. 2003; 22: 151–185.
  3. DiMasi JA, Grabowski HG, Hansen RW: Innovation in the pharmaceutical industry: New estimate of R&D costs. J. Health Econ. 2016; 47: 20–33
  4. Young R, Bekele T, Gunn A, et al.: Developing new health technologies for neglected diseases: A pipeline portfolio review and cost model. Gates Open Research. 2020; 2.
  5. Martin L, Hutchens M, Hawkins C, et al.: How much do clinical trials cost? Nat. Rev. Drug Discov. 2017; 16: 381–382